Dr Sarah Cocklin

Senior Analyst

Sarah has more than 9 years’ medical writing experience within the pharmaceutical industry, consulting, and academia.

She is a member of the PRMA Consulting medical writing team, with a focus on value communication projects such as value propositions and global value dossiers across a variety of therapy areas, including renal cell carcinoma, gastric and esophageal cancer, glioblastoma, osteoporosis, and psoriasis.

She comes from a strong regulatory writing background, including preparation of clinical study reports and sections of new drug application submissions. Prior to joining industry, Sarah held several postdoctoral positions in the US, including at New York (Alzheimer’s disease and vascular dementia) and Drexel universities (HIV and antibiotic pre-clinical drug development), as well as being faculty staff scientist at Harvard Medical School investigating Fc receptors and HIV vaccine immunology.

Sarah has a BSc in pharmacology from the University of Sunderland and a PhD in biochemistry from the University of Leeds.